Skip to main content
SpringerLink
Log in
Book cover

Bewegungsstörungen bei Psychischen Erkrankungen pp 29–59Cite as

Neuroleptika-induzierte vs. genuine Bewegungsstörungen

  • Chapter

Zusammenfassung

Zwei Jahre, nachdem Delay und Deniker (1952) anlässlich einer Konferenz in Luxembourg erstmals ihre Erfahrungen mit dem später Chlorpromazin genannten RP 4560 bei der Behandlung deliranter und psychotischer Patienten referiert hatten, berichtete der Schweizer Neurologe Hans Steck über ein reversibles, dosisabhängiges extrapyramidales Syndrom mit Parkinsonismus und Akathisie, das er unter der Behandlung mit Chlorpromazin und Reserpin an 111 von 299 (37%) meist chronisch schizophrenen Patienten beobachtet hatte (Steck 1954). In Anlehnung an eine vergleichbare Symptomatik im Verlauf der Encephalitis lethargica (sein Spezialgebiet) benannte Steck die beobachtete Symptomatik als »extrapyramidales-diencephalesº Syndrom. Aufgrund früherer Beobachtungen an chronisch Schizophrenen, bei denen die Entwicklung eines Parkinson-Syndroms im Rahmen einer zusätzlichen Erkrankung an Encephalitis lethargica zu einer Besserung der schizophrenen Symptomatik geführt hatte, entwickelte Steck die nach ihm benannte Hypothese, dass Chlorpromazin ähnlich einer Encephalitis den natürlichen Verlauf der psychotischen Krankheit von einem erregten Initialstadium zu einem akinetischen, durch Aktivitätsverlust charakterisierten Stadium bis hin zur Möglichkeit einer Spontanheilung beschleunigen würde.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Addonizio G, Alexopoulos GS (1988) Drug-induced dystonia in young and elderly patients. Am J Psychiatry 145:869–871

    CAS  PubMed  Google Scholar 

  • Aguilar EJ, Keshavan MS, Martinez-Quiles MD et al (1994) Predictors of acute dystonia in first-episode psychotic patients. Am J Psychiatry 151:1819–1821

    CAS  PubMed  Google Scholar 

  • American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DM-IV). APA, Washington, DC

    Google Scholar 

  • Arana GW, Goff DC, Baldessarini RJ, Keepers GA (1988) Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia. Am J Psychiatry 145:993–936

    CAS  PubMed  Google Scholar 

  • Arnold OH (1979) Schizophrene Exazerbationen: paradoxe Reaktionen auf Intensiv-Neuroleptika. In: Kryspin-Exner K, Hinterhuber H, Schubert H (Hrsg) Therapie akuter psychiatrischer Syndrome. Schattauer, Stuttgart New York, pp 165–168

    Google Scholar 

  • Asnis GM, Leopold MA, Duvoisin RC et al (1985) A survey of tardive dyskinesia. A double blind study. Pharmacopsychiatry 18:61-62

    Google Scholar 

  • Ayd FJ (1961) A survey of drug-induced extrapyramidal reactions. JAMA 175:1054–1060

    CAS  PubMed  Google Scholar 

  • Ayra DK (1994) Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry 165:728–733

    Google Scholar 

  • Baldessarini RJ, Cole JO, Davis JM et al (1980) Taskforce on the late neurological effects of antipsychotic drugs: Tardive dyskinesia. Summary of a task force report of the American Psychiatric Association. Am J Psychiatry 137:1163–1172

    Google Scholar 

  • Bandelow B, Grohmann R, Rüther E (1993) In: Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen. Enke, Stuttgart, S 166–183

    Google Scholar 

  • Barnes TRE, Braude WM (1985) Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 42:672–676

    Google Scholar 

  • Barsa JA, Kline (1956) Use of reserpine in disturbed psychatric patients. Am J Psychiatry 13:155–162

    Google Scholar 

  • Benkert O, Hippius H (1992) Psychiatrische Pharmakotherapie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Bennett JP, Landow ER, Dietrich S, Schuh LA (1994) Suppression of dyskinesias in advanced Parkinson’s disease: moderate daily clozapine doses provide long-term dyskinesia reduction. Movement Dis 9:409–414

    PubMed  Google Scholar 

  • Braude WM, Barnes TRE, Gore SM (1985) Clinical characteristics of akathisia: a systematic investigation of acute psyciatric inpatient admissions. Br J Psychiatry 143:139–150

    Google Scholar 

  • Bräunig P, Börner I, Krüger S (1995) Diagnostische Merkmale katatoner Schizophrenien. In: Bräunig P (Hrsg) Differenzierung katatoner und neuroleptika-induzierter Bewegungsstörungen. Thieme, Stuttgart, S 36–42

    Google Scholar 

  • Brenner J, Rheuban W (1978) The catatonic dilemma. Am J Psychiatry 135:1242–1243

    CAS  PubMed  Google Scholar 

  • Bing R (1923) Über einige bemerkenswerte Begleiterscheinungen der »extrapyramidalen Rigiditätº. Schweiz Med Wochenschr 4:167–171

    Google Scholar 

  • Branchey M, Branchey L (1984) Patterns of psychotropic drug use and tardive dyskinesia. J Clin Psychopharmacol 1:41–45

    Google Scholar 

  • Burke RE, Kang UJ (1988) Tardive dystonia: clinical aspects and treatment. In: Jankovic J, Tolosa E (eds) Facial dyskinesias. Raven Press, New York, pp 199–210 (Advances in neurology, vol 49)

    Google Scholar 

  • Carlsson A (1970) Biochemical aspects of abnormal move-ments induced by L-DOPA. In: Barbeau A, McDowell FH (eds) L-DOPA and parkinsonism. FA Davis, Philadelphia

    Google Scholar 

  • Casey DE (1994) Motor and mental aspects of acute extrapyramidal syndromes. Acta Psychiatr Scand 89 (Suppl 380):14–20

    Google Scholar 

  • Casey DE, Rabins P (1978) Tardive dyskinesia as a life-threatening illness. Am J Psychiatry 135:486–488

    CAS  PubMed  Google Scholar 

  • Chakos MH, Alvir JM, Woerner MG et al. (1996) Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Arch Gen Psychiatry 53:313–319

    CAS  PubMed  Google Scholar 

  • Chatterjee A, Chakos M, Koreen A et al (1995) The prevalence and correlates of acute extrapyramidal symptoms in never-medicated schizophenic patients. Am J Psychiatry 152:1724–1729

    CAS  PubMed  Google Scholar 

  • Chouinard G, Jones BD (1980) Neuroleptic-induced supersensitivity psychosis: clinical and pharmacological characteristics. Am J Psychiatry 137:16–21

    CAS  PubMed  Google Scholar 

  • Conrad B (1996) Pathophysiologie der Bewegungsstörungen. In: Conrad B, Ceballos AO (Hrsg) Bewegungsstörungen in der Neurologie. Thieme, Stuttgart New York, pp 11–29

    Google Scholar 

  • Davis KL, Berger PA, Hollister LE (1976) Tardive dyskinesia and depressive illness. J Clin Pschopharmacol 2:350–354

    Google Scholar 

  • Crow TJ, Cross AJ, Johnstone EC (1982) Abnormal involuntary movements in schizophrenia: Are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors? J Clin Psychopharmacol 5:336–340

    Google Scholar 

  • Delay J, Deniker P, Green A, Moronet P (1957) Les syndromes excito moteurs provoques par les medicaments neuroleptics. Presse Med 65:1771–1774

    CAS  PubMed  Google Scholar 

  • Dose M (1993) Neuroleptisch bedingte Spätdyskinesien. Synthelabo, Schürholz

    Google Scholar 

  • Dose M (1993) Spektrum Neuroleptika und andere Psychopharmaka. Aesopus, Basel

    Google Scholar 

  • Dose M (1998) Unerwünschte psychische Wirkungen. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka. Ein Therapie-Handbuch, Bd 4: Neuroleptika. Springer, Wien New York, pp 166–176

    Google Scholar 

  • Dose M (2000) Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes. Pharmacopsychiatry 33 (Suppl):3–13

    PubMed  Google Scholar 

  • Dose M, Tempel HD (2000) Abuse potential of anticholinergics. Pharmacopsychiatry 33 (Suppl):43–46

    CAS  PubMed  Google Scholar 

  • Ekbom KA (1944) Irritable legs. Acta Med Scand 118:197–198

    Google Scholar 

  • Faheem AD, Brightwell DR, Burton GC et al (1982) Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: tardive dyskinesia? Am J Psychiatry 139:517–518

    CAS  PubMed  Google Scholar 

  • Farde L, Nordstroem A, Wiesel F et al (1993) Positron emission tomographic analysis of central Dt and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch Gen Psychiatry 49:539–544

    Google Scholar 

  • Faurbye A, Rasch PJ, Peterson PB et al (1964) Neurological symptoms in pharmacotherapy of psychoses. Acta Psychiatr Scand 40:10–27

    CAS  PubMed  Google Scholar 

  • Fleischhacker WW, Roth SD, Kane J (1990) The pharmacological treatment of neuroleptic-induced akathisia. J Clin Pschopharmacol 10:12–21

    CAS  Google Scholar 

  • Flügel F, Bente D (1956) Das akinetisch-abulische Syndrom und seine Bedeutung für die pharmakologisch-psychiatrische Forschung. Dtsch Med Wochenschr

    Google Scholar 

  • Freyhan FA (1957) Psychomotilität, extrapyramidale Syndrome und Wirkungsweisen neuroleptischer Therapien. Nervenarzt 27:504–509

    Google Scholar 

  • Freyhan FA (1958) Extrapyramidal symptoms and other side effects in trifluoperazine: clinical and pharmacological aspects. Lea & Febiger, Philadelphia

    Google Scholar 

  • Gardos G, Samu I, Kallos M et al (1980) Absence of severe tardive dyskinesia in Hungarian schizophrenic out-patients. Psychopharmacology 71:29–34

    CAS  PubMed  Google Scholar 

  • Gardos G, Teicher MH, Lipinski JF et al (1992) Quantitative as-sessment of psychomotor activity in patients with neuro-leptic-induced akathisia. Prog Neuropsychopharmacol Biol Psychiatry 16:27–37

    CAS  PubMed  Google Scholar 

  • Gelenberg AJ, Mandel MR (1977) Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 34:947–950

    CAS  PubMed  Google Scholar 

  • Gerlach J, Korsgaard S, Clemmensen P et al (1993) The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand 87:244–252

    CAS  PubMed  Google Scholar 

  • Gibb WR, Lees AJ (1986) The clinical phenomenon of akathisia. J Neurol Neurosurg Psychiatry 49:861–866

    CAS  PubMed  Google Scholar 

  • Glazer WM, Morgenstern H, Doucette JT (1993) Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. J Clin Psychiatry 54:133–139

    CAS  PubMed  Google Scholar 

  • Grohmann R, Rüther E (1994) Neuroleptika. In: Grohmann R, Rüther E, Schmidt LG (Hrsg) Unerwünschte Wirkungen von Psychopharmaka. Springer, Berlin Heidelberg New York, S 42–133

    Google Scholar 

  • Haag H, Greil W, Schertel M et al (1985) Tardive dyskinesia and medication history. Pharmacopsychiatry 18:35–36

    Google Scholar 

  • Haag H, Rüther E, Hippius H (1992) Tardive Dyskinesia: WHO Expert Series on Biological Psychiatry, vol I. Hogrefe & Huber, Seattle

    Google Scholar 

  • Haase HJ (1954) Über Vorkommen und Deutung des psycho-motorischen Parkinson-Syndroms bei Megaphen-bzw. Largactil-Dauerbehandlung. Nervenarzt 25:486–492

    CAS  PubMed  Google Scholar 

  • Haskovec ML (1901) L’akathisie. Rev Neurol 9:1107–1109

    Google Scholar 

  • Hinterhuber H, Hackenberg B (1986) Neuroleptische Turbulenzphasen. In: Hinterhuber H, Kulhanek F (Hrsg) Seiteneffekte und Störwirkungen der Psychopharmaka. Schattauer, Stuttgart New York, pp 49–56

    Google Scholar 

  • Hippius H, Logemann G (1970) Zur Wirkung von Dioxyphenylalanin (L-DOPA) auf extrapyramidalmotorische Hyperki-nesen nach langfristiger neuroleptischer Therapie. Arzneim Forsch 20:894–895

    CAS  Google Scholar 

  • Höffler J, Bräunig P (1995) Abnahme der Häufigkeit katatoner Schizophrenien im Epochenvergleich. In: Bräunig P (Hrsg) Differenzierung katatoner und neuroleptika-induzierter Bewegungsstörungen. Thieme, Stuttgart, S 32–35

    Google Scholar 

  • Höffler J, Bräunig P, Börner I, Krüger S (1995) Untersuchung zum Einfluss veränderter diagnostischer Kriterien auf die Häufigkeit der Diagnose »katatone Schizophrenieº. In: Bräunig P (Hrsg) Differenzierung katatoner und neuroleptika-induzierter Bewegungsstörungen. Thieme, Stuttgat, S 43–46

    Google Scholar 

  • Janzarik W (1954) Zur Psychopathologie der Megaphenwirkung. Nervenarzt 25:330–335

    CAS  PubMed  Google Scholar 

  • Jahn T (1999) Diskrete motorische Störungen bei Schizophrenie. In: Bungard W, Frey D, Lantermann ED et al (Hrsg) Fortschritte der psychologischen Forschung 40. Psychologie Verlags Union, Weinheim

    Google Scholar 

  • Jaspers K (1965) Allgemeine Psychopathologie, 8. Aufl. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Jeste DV, Wyatt RJ (1982) Understanding and treating tardive dyskinesia. The Guilford Press, New York London

    Google Scholar 

  • Jeste DV, Caliguri MP, Paulson JS et al (1995) Risk of tardive dyskinesia in older patients: a prospective longitudinal study of266 outpatients. Arch Gen Psychiatry 52:756–765

    CAS  PubMed  Google Scholar 

  • Johnstone EC, Crow TJ, Ferrier IN et al (1983) Adverse effects of anticholinergic medication on positive schizophrenic symptoms. Psychol Med 13:513–527

    CAS  PubMed  Google Scholar 

  • Kahlbaum KL (1874) Die Katatonie oder das Spannungsirresein. Eine klinische Form psychischer Krankheit. Hirschwald, Berlin

    Google Scholar 

  • Kane JM, Smith JM (1982) Tardive dyskinesia. Arch Gen Psychiatry 39:473–481

    CAS  PubMed  Google Scholar 

  • Kane JM, Woerner M, Weinhold P et al (1984) Incidence of tardive dyskinesia: Five-year data from a prospective study. Psychopharmacol Bull 20:387–389

    CAS  PubMed  Google Scholar 

  • Kane JM, Woerner M, Borenstein P et al (1986) Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol Bull 1:254–258

    Google Scholar 

  • Kane JM (1990) Spätdyskinesien: Prävalenz, Inzidenz und Risikofaktoren. In: Hinterhuber H, Kulhanek F, Fleischhacker WW (Hrsg) Kombination therapeutischer Strategien bei schizophrenen Erkrankungen. Vieweg, Braunschweig, S 181–193

    Google Scholar 

  • Kastrup O, Gastpar M, Schwartz M (1994) Acute dystonia due to clozapine. J Neurol Neurosurg Psychiatry 57:119

    CAS  PubMed  Google Scholar 

  • Keepers GA, Casey DE (1987) Prediction of neuroleptic induced dystonia. J Clin Psychopharmacol 7:342–344

    CAS  PubMed  Google Scholar 

  • Kendler KS (1976) A medical student’s experience with akathisia. Am J Psychiatry 133:454

    Google Scholar 

  • Kennedy PF, Hershon HI, McGuire RJ (1971) Extrapyramidal disorders after prolonged phenothiazine therapy. Br J Psychiatry 118:508–518

    Google Scholar 

  • Klawans HL (1973) The pharmacology of tardive dyskinesia. Am J Psychiatry 130:82–86

    PubMed  Google Scholar 

  • Kleist K (1908) Untersuchungen zur Kenntnis der psychomotorischen Bewegungsstörungen bei Geisteskranken. Thieme, Leipzig

    Google Scholar 

  • Kolbe H, Clow A, Jenner P, Marsden CD (1981) Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release to supersensitive postsynaptic receptors. Neurology (NY) 31:434–439

    CAS  PubMed  Google Scholar 

  • Korczyn AD, Goldberg GJ (1972) Intravenous diazepam in drug-related dystonic reactions. Br J Psychiatry 121:75–77

    CAS  PubMed  Google Scholar 

  • Kovacic B, Domino EF (1982) A monkey model of tardive dyskinesia (TD). Evidence that reversible TD may turn into irreversible TD. J Clin Psychopharmacol 5:305–307

    Google Scholar 

  • Kraepelin E (1913) Psychiatrie. Ein Lehrbuch für Studierende und Ärzte, 8. Aufl. (Band III). Barth, Leipzig

    Google Scholar 

  • Kuhlenkampff C, Tarno wG (1956) Ein eigentümliches Syndrom im oralen Bereich bei Megaphenapplikation. Nervenarzt 27:178–180

    Google Scholar 

  • Larson EW, Pfenning MA, Richelson E (1991) Selectivity of anti-muscarinic compounds for muscarinic receptors of human brain and heart. Psychopharmacology 103:162–165

    CAS  PubMed  Google Scholar 

  • Lieberman JA, Saltz BL, Johns CA et al (1991) The effects of clozapine on tardive dyskinesia. Br J Psychiatry 158: 503–510

    CAS  PubMed  Google Scholar 

  • Leonhard K (1936) Die defektschizophrenen Krankheitsbilder. Thieme, Leipzig

    Google Scholar 

  • Lipinski JF, Zubenko GS, Barreira P, Cohen BM (1983) Propranolol in the treatment of neuroleptic-induced akathisia. Lancet 2:685–686

    CAS  PubMed  Google Scholar 

  • Magliozzi JR, Gillespie H, Lombrozo L, Hollister LE (1985) Mood alteration following oral and intravenous haloperidol and relationship to drug concentration in normal subjects. J Clin Pharmacol 25:285–290

    CAS  PubMed  Google Scholar 

  • Marsden CD, Jenner P (1980) The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med 10:55–72

    CAS  PubMed  Google Scholar 

  • McCreadie RG, Ohaeri JU (1994) Movement disorder in never and minimally treated Nigerian schizophrenic pattients. Br J Psychiatry 164:184–189

    CAS  PubMed  Google Scholar 

  • McCreadie RG, Thara R, Kamath S et al (1996) Abnormal movements in never medicated Indian patients with schizophrenia. Br J Psychiatry 168:221–226

    CAS  PubMed  Google Scholar 

  • McEvoy JP, McCue M, Freter S (1987) Replacement of chronically administered anticholinergic drugs by amantadine in out-patient management of chronic schizophrenia. Curr Ther 9:429–433

    CAS  Google Scholar 

  • McEvoy JP, McCue M, Spring B et al (1987) Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers. Am J Psychiatry 144:573–577

    CAS  PubMed  Google Scholar 

  • Meltzer HY, Matsabura S, Lee JC (1989) Classification of typical and atypical antipsychotic drugs on the basis of D-1, D-2 and serotonine pKi values. J Pharmacol Exp Ther 251:238–246

    CAS  PubMed  Google Scholar 

  • Morgenstern H, Glazer WM (1983) Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Arch Gen Psychiatry 50:723–733

    Google Scholar 

  • Moleman P, Janzen G, Bargen BA (1986) Relationship between age and incidence of parkinsonism in psychiatric patients treated with haloperidol. Am J Psychiatry 143:232–234

    CAS  PubMed  Google Scholar 

  • Nordstrom AL, Farde L, Halldin C (1992) Time course of D2-dopamine receptor occupancy examined by PETafter single oral doses of haloperidol. Psychopharmacology 106:433–438

    CAS  PubMed  Google Scholar 

  • Obeso JA, Rothwell JC, Lang AE, Marsden CD (1983) Myoclonic dystonia. Neurology (Cleveland) 33:825–830

    CAS  PubMed  Google Scholar 

  • Owens DG, Johnstone EC, Frith CD (1982) Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry 39:452–461

    CAS  PubMed  Google Scholar 

  • Owens DG (1999) Aguide to the extrapyramidal side-effects of antipsychotic drugs. Cambridge University Press

    Google Scholar 

  • Paulson GW, Crane GE (1975) Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines. Clin Pediatr 14:953–955

    CAS  Google Scholar 

  • Poewe W, Ceballos-Baumann AO, Conrad B (1996) Parkinsonkrankheit. In: Conrad B, Ceballos AO (Hrsg) Bewegungsstörungen in der Neurologie. Thieme, Stuttgart New York, S 30–68

    Google Scholar 

  • Rainier-Pope CR (1979) Treatment with diazepam of children with drug-induced extrapyramidal symptoms. South African Med J 55:328–330

    CAS  Google Scholar 

  • Remington G, Bezchlibnyk-Butler K (1996) Management of acute antipsychotic-induced extrapyramidal syndromes. CNS Drugs 5 (Suppl 1):21–35

    Google Scholar 

  • Rogers D (1985) The motor disorders of severe psychiatric ill-ness: a conflict of paradigms. Br J Psychiatry 147:221–232

    CAS  PubMed  Google Scholar 

  • Rogers D (1992) Motor disorder in psychiatry. Towards a neurological psychiatry. Wiley, Chichester

    Google Scholar 

  • Rosen JN (1953) Direct analysis. Grune & Stratten, New York

    Google Scholar 

  • Rupniak NMJ, Jenner P, Marsden CD (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88: 403–419

    CAS  PubMed  Google Scholar 

  • Sachdev P (1995) Akathisia and restless legs. Cambridge University Press

    Google Scholar 

  • Sachdev P, Kruk J (1994) Clinical characteristics and predisposing factors in acute drug-induced akathisia. Arch Gen Psychiatry 51:963–974

    CAS  PubMed  Google Scholar 

  • Sarwer-Foner GJ, Ogle W (1956) Psychosis and enhanced anxiety produced by reserpine and chlorpromazine. Can Med Assoc J 74:526–532

    CAS  PubMed Central  PubMed  Google Scholar 

  • Schönecker M (1957) Beitrag zur Mitteilung von Kuhlenkampff und Tarnow: ein eigentümliches Syndrom im oralen Bereich bei Megaphenapplikation. Nervenarzt 28:35

    Google Scholar 

  • Schooler NR, Kane JM (1982) Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39:486–487

    CAS  PubMed  Google Scholar 

  • Sicard JA (1923) Akathisie et tasikinesie. Rev Neurol 31:265–266

    Google Scholar 

  • Sigwald J, Grossiord A, Duriel P et al (1947) Le traitement de maladie de Parkinson et des manifestations extrapyramidalles par le diethylaminomethyl n-thiophenylamine (2987 RP): resultats d’une annee d’application. Rev Neurol 79:683–687

    Google Scholar 

  • Sigwald J, Bouttier D, Courvoisier M (1959) Les accidents neurologiques des medications neuroleptiques. Rev Neurol 100:553

    CAS  PubMed  Google Scholar 

  • Sigwald J, Bouttier D, Raymond C, Piot C (1959) Quatre cas de dyskinesie facio-bucco-linguo-masticatice a evolution prolongee secondaire a un traitement par les neurolep-tiques. Rev Neurol (Paris) 100:751–755

    CAS  PubMed  Google Scholar 

  • Smith RC, Tamminga CA, Haraszti J et al (1977) Effects of dopamine agonists in tardive dyskinesia. Am J Psychiatry 134:763–768

    CAS  PubMed  Google Scholar 

  • Stahl SM (1985) Akathisia and tardive dyskinesia. Changing concepts. Arch Gen Psychiatry 42:874–878

    Google Scholar 

  • Steck H (1954) Le syndrome extrapyramidal et diencephalique au cours des traitements au largactil et au serpasil. Ann Med Psych 112:737–743

    CAS  Google Scholar 

  • Tan CH, Chiang PC, Ng LL, Chee KT (1994) Oculogyric spasm in Asian psychiatric in-patients on maintenance medication. Br J Psychiatry 165:381–383

    CAS  PubMed  Google Scholar 

  • Uhrbrand L, Faurbye A (1960) Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy. Psychopharmacology 1:408–418

    Google Scholar 

  • Van Putten T, Multipassi LR, Malkin MD (1974) Phenothiazine-induced decompensation. Arch Gen Psychiatry 30:102–106

    PubMed  Google Scholar 

  • Van Putten T, May PRA (1978) Akinetic depression in schizophrenia. Arch Gen Psychiatry 35:1101–1107

    PubMed  Google Scholar 

  • Van Putten T, Marder SR (1987) Behavioral toxicity of antipsychotic drugs. J Clin Psychiatry 48 (Suppl 9):13–19

    PubMed  Google Scholar 

  • Villeneuve A (1972) The Rabbit syndrome: a peculiar extrapyramidal reaction. Can Psychiatr Assoc J 17 (Suppl 2):69–72

    Google Scholar 

  • Von Ditfurth H (1956) Schauanfälle bei der Zwangskrankheit infolge Megapheneinwirkung. Nervenarzt 28:177–179

    Google Scholar 

  • Weiden PJ, Mann JJ, Haas G et al (1987) Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. Am J Psychiatry 144:1148–1153

    CAS  PubMed  Google Scholar 

  • Weltgesundheitsorganisation (1991) Internationale Klassifikation psychischer Störungen: ICD-10, Kapitel V (F), klinisch-diagnostische Leitlinien. Dilling H, Mombour W, Schmidt MH (Hrsg) Huber, Bern Göttingen Toronto

    Google Scholar 

  • Wernicke C (1900) Grundriss der Psychiatrie. Thieme, Leipzig

    Google Scholar 

  • Wibur R, Kulik AV (1983) Propranolol for akathisia. Lancet 2:917

    Google Scholar 

  • Wilson SAK (1912) Progressive lenticular degeneration: a famil-ial nervous disease associated with cirrhosis of the liver. Brain 34:295–509

    Google Scholar 

  • Woerner MG, Kane JM, Lieberman JA et al (1991) The prevalence of tardive dyskinesia. J Clin Psychopharmacol 11:34–42

    CAS  PubMed  Google Scholar 

  • Yassa R, Ghadirian AM, Schwartz G (1983) Prevalence of tardive dyskinesia in affective disorder patients. J Clin Psychiatry 44:410–412

    CAS  PubMed  Google Scholar 

  • Zubenko GS, Lipinski JF, Cohen BM, Barreira PJ (1984) Comparison of metoprolol and propranolol in the treatment of akathisia. Psychiatry Res 11:143–149

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. Matthias Dose
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinikum rechts der Isar Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München, Ismaninger Str. 22, München, 81675, Germany

    Thomas Jahn Dipl.-Psych.

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dose, M. (2004). Neuroleptika-induzierte vs. genuine Bewegungsstörungen. In: Jahn, T. (eds) Bewegungsstörungen bei Psychischen Erkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18533-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18533-5_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40773-7

  • Online ISBN: 978-3-642-18533-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation